Abeona Therapeutics Receives U.S. Orphan Drug Designations for treatment of Sanfilippo Syndromes A and B May 12, 2014
Abeona Therapeutics Closes $750,000 in Seed Round to Develop Therapies for Children Suffering from Rare Sanfilippo Diseases Dec 16, 2013
Abeona Therapeutics and Nationwide Children's Hospital receive prestigious Global Genes "Champions of Hope" award for Patient Advocacy Oct 9, 2013
